Some scholars have interfered with the expression of TGF-β1 to confirm that EGCG inhibits the epithelial transformation and invasion of thyroid cancer cells by regulating the TGF-β1-Smad4 pathway. This evidence concerns the gene SMAD4 and thyroid gland carcinoma.